Cargando…

Evaluation of pancreatic function in patients with plaque psoriasis

Psoriasis is a chronic inflammatory dermatosis with periods of exacerbation and remission. Prevalence of psoriasis is estimated at 1–3% of the population of Europe and the United States of America. The disease process may affect the skin, nails and joints. Perception of psoriasis as not only a skin...

Descripción completa

Detalles Bibliográficos
Autor principal:	Białecka, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399677/ https://www.ncbi.nlm.nih.gov/pubmed/37545836 http://dx.doi.org/10.5114/ada.2023.129400

Ejemplares similares

Atherosclerosis attacks in patients with psoriasis vulgaris but without a relationship with the severity and course of the disease
por: Białecka, Agnieszka, et al.
Publicado: (2021)

Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis
por: Reddy, Vidhatha, et al.
Publicado: (2020)

Prolidase activity in chronic plaque psoriasis patients
por: Sürücü, Hacer Altın, et al.
Publicado: (2015)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008)

The influence of body weight of patients with chronic plaque psoriasis on biological treatment response
por: Kisielnicka, Anna, et al.
Publicado: (2020)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
por: Gambardella, Alessio
Publicado: (2019)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Ustekinumab in the therapy of chronic plaque psoriasis
por: O’Neill, Jenna L, et al.
Publicado: (2009)

Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
por: Yang, Eric J, et al.
Publicado: (2019)

Guselkumab for plaque psoriasis
Publicado: (2019)

Bimekizumab for plaque psoriasis
Publicado: (2022)

Treating pediatric plaque psoriasis: challenges and solutions
por: Thomas, Jayakar, et al.
Publicado: (2016)

Sonographic Evaluation of Subclinical Enthesopathy in Patients of Chronic Plaque Psoriasis
por: Vyas, Kapil, et al.
Publicado: (2020)

Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
por: Camiña-Conforto, Gemma, et al.
Publicado: (2023)

Contemporary treatment patterns in plaque psoriasis and psoriatic arthritis
por: Jenerowicz, Dorota, et al.
Publicado: (2020)

Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trial
por: Beylot-Barry, Marie, et al.
Publicado: (2022)

Increased red blood cell distribution width in patients with plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2021)

Stigmatization among Patients with Plaque Psoriasis
por: Jankowiak, Barbara, et al.
Publicado: (2023)

The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis
por: Jenneck, Claudia, et al.
Publicado: (2007)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Mercuri, Santo Raffaele, et al.
Publicado: (2010)

Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
por: Galluzzo, M, et al.
Publicado: (2019)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016)

Emerging targeted therapies for plaque psoriasis – impact of ixekizumab
por: Kazemi, Tiana, et al.
Publicado: (2017)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
por: Mahé, Emmanuel
Publicado: (2020)

Analysis of selected genetic variants in psoriasis susceptibility and response to treatment
por: Malinowski, Damian, et al.
Publicado: (2022)

Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program “Treatment of moderate and severe forms of plaque psoriasis (B.47)” of the National Health Fund in Poland
por: Owczarek, Witold, et al.
Publicado: (2021)

Cold stimulation test in patients with plaque psoriasis
por: Aleksiev, Teodor, et al.
Publicado: (2023)

Efficacy of Methotrexate in patients with plaque type psoriasis
por: Haider, Sabiqa, et al.
Publicado: (2014)

The content validity of the PSS in patients with plaque psoriasis
por: Rentz, A. M., et al.
Publicado: (2017)

Risk of respiratory infection in patients with plaque psoriasis
por: Svedbom, Axel, et al.
Publicado: (2021)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
por: Jin, Joy Q, et al.
Publicado: (2023)

Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
por: Spencer, Riley K, et al.
Publicado: (2023)

Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Ren, Vicky, et al.
Publicado: (2013)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon, Sahil, et al.
Publicado: (2017)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017)

Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
por: Gisondi, Paolo, et al.
Publicado: (2020)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
por: Light, Jeremy G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gh695e39du6dpr058jd3km13mc